Palanas, Jane D.

HRN: 23-90-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 750MG (VIAL)
10/17/2023
10/23/2023
IVT
750mg
Q8
UTI
Waiting Final Action 
10/18/2023
CEFTRIAXONE 1G (VIAL)
10/18/2023
10/24/2023
IV
2g
Q24
Uti
Waiting Final Action 
10/18/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/18/2023
10/25/2023
ORAL
1ml
Tid
Candidal Stomatitis
Waiting Final Action 
10/21/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
10/21/2023
10/27/2023
IV
285mg
OD
Sepsis
Waiting Final Action 
10/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/21/2023
10/27/2023
IVT
300mg
Q6
Skin Infection
Waiting Final Action 
10/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/21/2023
10/27/2023
IV
230mg
Q8
Sepsis
Waiting Final Action 
10/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/22/2023
10/29/2023
IV
2.25g
Q6
AGN; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: